Treatment of ST-segment elevation myocardial infarction during COVID-19 pandemic. [Review]

MedStar author(s):
Citation: Cardiovascular Revascularization Medicine. 21(8):1024-1029, 2020 08.PMID: 32471712Institution: MedStar Heart & Vascular InstituteForm of publication: Journal ArticleMedline article type(s): Journal Article | ReviewSubject headings: *Betacoronavirus | *Coronavirus Infections/ep [Epidemiology] | *Pandemics | *Percutaneous Coronary Intervention/mt [Methods] | *Pneumonia, Viral/ep [Epidemiology] | *ST Elevation Myocardial Infarction/su [Surgery] | Comorbidity | Coronary Angiography | Humans | ST Elevation Myocardial Infarction/di [Diagnosis] | ST Elevation Myocardial Infarction/ep [Epidemiology]Year: 2020ISSN:
  • 1878-0938
Name of journal: Cardiovascular revascularization medicine : including molecular interventionsAbstract: The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy. Copyright (c) 2020 Elsevier Inc. All rights reserved.All authors: Ben-Dor I, Case BC, Chezar-Azerrad C, Forrestal BJ, Hashim H, Mintz GS, Satler LF, Waksman R, Yerasi COriginally published: Cardiovascular Revascularization Medicine. 2020 May 21Fiscal year: FY2021Fiscal year of original publication: FY2020Digital Object Identifier: Date added to catalog: 2020-08-26
Holdings
Item type Current library Collection Call number Status Date due Barcode
Journal Article MedStar Authors Catalog Article 32471712 Available 32471712

The number of cases of the coronavirus-induced disease-2019 (COVID-19) continues to increase exponentially worldwide. In this crisis situation, the management of ST-segment elevation myocardial infarction (STEMI) is challenging. In this review, we outline the risk and benefits of primary PCI vs. thrombolysis for STEMI. While thrombolysis may seem like a good choice, many patients have a contraindication and could end-up using more resources. Also, with a high probability of the angiogram showing non-obstructed coronary arteries during acute infections, primary PCI should be the preferred strategy. Copyright (c) 2020 Elsevier Inc. All rights reserved.

English

Powered by Koha